- Home
- GDV vs CPRX Comparison
GDV vs CPRX Comparison
Compare GDV & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDV
- CPRX
- Stock Information
- Founded
- GDV 2003
- CPRX 2002
- Country
- GDV United States
- CPRX United States
- Employees
- GDV N/A
- CPRX N/A
- Industry
- GDV Investment Managers
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- GDV Finance
- CPRX Health Care
- Exchange
- GDV Nasdaq
- CPRX Nasdaq
- Market Cap
- GDV 2.2B
- CPRX 2.6B
- IPO Year
- GDV N/A
- CPRX 2006
- Fundamental
- Price
- GDV $27.09
- CPRX $21.26
- Analyst Decision
- GDV
- CPRX Strong Buy
- Analyst Count
- GDV 0
- CPRX 5
- Target Price
- GDV N/A
- CPRX $33.20
- AVG Volume (30 Days)
- GDV 186.0K
- CPRX 1.5M
- Earning Date
- GDV 01-01-0001
- CPRX 11-05-2025
- Dividend Yield
- GDV 5.81%
- CPRX N/A
- EPS Growth
- GDV N/A
- CPRX 183.96
- EPS
- GDV N/A
- CPRX 1.65
- Revenue
- GDV N/A
- CPRX $558,499,000.00
- Revenue This Year
- GDV N/A
- CPRX $16.51
- Revenue Next Year
- GDV N/A
- CPRX $9.58
- P/E Ratio
- GDV N/A
- CPRX $12.88
- Revenue Growth
- GDV N/A
- CPRX 28.55
- 52 Week Low
- GDV $18.04
- CPRX $19.05
- 52 Week High
- GDV $23.00
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- GDV 52.29
- CPRX 60.61
- Support Level
- GDV $26.46
- CPRX $19.90
- Resistance Level
- GDV $27.40
- CPRX $21.17
- Average True Range (ATR)
- GDV 0.35
- CPRX 0.68
- MACD
- GDV -0.05
- CPRX 0.08
- Stochastic Oscillator
- GDV 67.02
- CPRX 73.52
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).